Desmopressin Acetate NDC 39822-6250

NDC codes

FDA NDC Directory

Product NDC (as listed)39822-6250Labeler and product segments. Claims need a package NDC.

Product NDC at billing width39822-6250Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
39822-6250-1	39822625001	1 VIAL in 1 CARTON (39822-6250-1) / 10 mL in 1 VIALMarketed from Mar 22, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desmopressin Acetate
Generic name (nonproprietary): desmopressin acetate
Active ingredients: Desmopressin acetate — 4 ug/mL
Dosage form: Injection, Solution
Route: Intravenous, Subcutaneous
Labeler: XGen Pharmaceuticals DJB, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210223
Marketing start: Mar 22, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Increased Coagulation Factor VIII Activity (Physiologic effect)Increased Coagulation Factor VIII Concentration (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 39822-6250_0ec4ffe1-0ee2-fc69-e063-6394a90ab7fbSPL ID 0ec4ffe1-0ee2-fc69-e063-6394a90ab7fbSPL set ID 1052a869-b64d-655d-e063-6294a90ad0e2RxCUI 849501, 1723232UNII XB13HYU18UUPC 0339822625017, 0339822620012
Pharmacologic class: Factor VIII Activator; Vasopressin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N439822625001 followed by a unit qualifier and the quantity

Package 39822-6250-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 22, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Desmopressin acetate injection is a vasopressin analog used for: Central Diabetes Insipidus - as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. ( 1.1 ) Hemophilia A - for patients with factor VIII coagulant activity levels greater than 5% to maintain hemostasis during surgical procedures and postoperatively or reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding. ( 1.2 ) von Willebrand's disease (Type I) - for patients with mild to moderate disease …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210223

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210223
Product	Strength	Form · route	Labeler	Product NDC
Desmopressin Acetate	Desmopressin acetate 40 ug/10mL	InjectionIntravenous, Subcutaneous	UBI Pharma Inc.	72843-440
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	InjectionIntravenous, Subcutaneous	UBI Pharma Inc.	72843-461
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous, Subcutaneous	Avenacy, Inc.	83634-451
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous, Subcutaneous	The J. Molner Company LLC	83148-126
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	Injection, SolutionIntravenous, Subcutaneous	XGen Pharmaceuticals DJB, Inc.	39822-6200